In summary, we found that IFN-α exerted anti-tumor effect on bladder cancer cells through the inhibition of TPL2-NF/κB-COX2 pathway and TPL2-ERK-PDE4D mediated cAMP signaling (Fig. 6). Here, PTGS2 is linked to urinary bladder carcinoma.